20
International Medication Systems Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is HEPARIN SODIUM USP, with a corresponding US DMF Number 26070.
Remarkably, this DMF maintains an Active status since its submission on June 15, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 30, 2013, and payment made on December 12, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II